Sort
141,003 grants matching “cytokine”
Impact of low IL-10 levels at birth and leukemia risk
$624,355Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2016 · CA
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$624,332Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2020 · CA
The role of circulating meta-inflammatory monocytes in adolescent insulin resistance
$624,302Kanakadurga Singer · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design
$624,293Jeffrey David Klausner · University Of Southern California · R01 · FY2021 · AI
INHALED TOBRAMYCIN IN YOUNG CYSTIC FIBROSIS PATIENTS
$624,275Seattle Children'S Hospital · R01 · FY2000 · DK
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE
$624,257Devendra K. Agrawal · Creighton University · R01 · FY2012 · HL
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE
$624,257Devendra K. Agrawal · Creighton University · R01 · FY2016 · HL
Cytokines and Inflammatory Bowel Disease
$624,239Fabio Cominelli · Case Western Reserve University · R01 · FY2022 · DK
Cytokines and Inflammatory Bowel Disease
$624,239Fabio Cominelli · Case Western Reserve University · R01 · FY2020 · DK
Cytokines and Inflammatory Bowel Disease
$624,239Fabio Cominelli · Case Western Reserve University · R01 · FY2021 · DK
Core C - Mutagenesis, Screening and Cryopreservation
$624,221Lucienne Chatenoud · Ut Southwestern Medical Center · P01 · FY2023 · AI
Properties of stored RBCs: minimization of immune and vascular reactivity
$624,221Philip J Norris · Vitalant · R01 · FY2009 · HL
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov
$624,179Protul Shrikant · Roswell Park Cancer Institute Corp · P50 · FY2017 · CA
Therapy (CHT) for Asthma
$624,170Xiu-Min Li · Icahn School Of Medicine At Mount Sinai · P01 · FY2008 · AT
Astrocytic OSMR/JAK/STAT signaling in AD
$624,157Qin Wang · Augusta University · R01 · FY2024 · AG
Epidemiology of Diabetes Complications (EDC) Phase II: renewal
$624,124Trevor J. Orchard · University Of Pittsburgh At Pittsburgh · R37 · FY2015 · DK
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1
$624,089Chuanju Liu · New York University School Of Medicine · R01 · FY2018 · AR
Core D: Biomarker and Bio-Informatics Core
$624,089Raajit Rampal · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity
$624,088Yoshihiro Kawaoka · Oregon Health & Science University · U54 · FY2011 · AI
Protection of Developing White Matter during Cardiac Surgery
$624,034Richard A Jonas · Children'S Research Institute · R01 · FY2014 · HL
Influenza vaccine failure in adults over age 75: role of chronic CMV infection
$624,028Sean X Leng · Johns Hopkins University · R01 · FY2017 · AI
Function of T cells at the Maternal-Fetal Interface
$624,015Liza Konnikova · Yale University · R01 · FY2025 · AI
DEVELOPMENT OF BISPECIFIC, T-CELL ENGAGING, CYTOKINE-LOADED NANOPARTICLES (BITEOKINES) FOR THE TREATMENT OF CHILDHOOD CANCERS
$624,000Emory University · · FY2019 · Defense Health Agency
Novel Role for the P2Y2 Receptor in the Autoimmune Disease Sjogren's Syndrome
$623,962Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2017 · DE
Novel Role for the P2Y2 Receptor in the Autoimmune Disease Sjogren's Syndrome
$623,962Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2020 · DE